Cambridge Investment Research Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Buy
49,827
+1,762
+4% +$487K 0.02% 630
2026
Q1
$14.2M Sell
48,065
-1,497
-3% -$445K 0.04% 484
2025
Q4
$13.5M Buy
49,562
+2,501
+5% +$680K 0.04% 482
2025
Q3
$12.7M Buy
47,061
+535
+1% +$146K 0.03% 486
2025
Q2
$12.8M Buy
46,526
+5,110
+12% +$1.39M 0.04% 456
2025
Q1
$11M Sell
41,416
-586
-1% -$145K 0.04% 471
2024
Q4
$9.75M Sell
42,002
-1,223
-3% -$281K 0.03% 501
2024
Q3
$9.54M Buy
43,225
+3,077
+8% +$637K 0.03% 520
2024
Q2
$7.89M Sell
40,148
-13,765
-26% -$2.84M 0.03% 556
2024
Q1
$11.6M Buy
53,913
+4,684
+10% +$984K 0.04% 396
2023
Q4
$10.4M Buy
49,229
+2,441
+5% +$521K 0.04% 395
2023
Q3
$9.37M Buy
46,788
+5,909
+14% +$1.17M 0.04% 400
2023
Q2
$7.58M Buy
40,879
+1,445
+4% +$267K 0.03% 478
2023
Q1
$7.55M Buy
39,434
+2,378
+6% +$430K 0.04% 454
2022
Q4
$6.23M Sell
37,056
-364
-1% -$63.3K 0.03% 510
2022
Q3
$6.63M Buy
37,420
+251
+0.7% +$49.6K 0.04% 451
2022
Q2
$7.61M Buy
37,169
+1,879
+5% +$398K 0.04% 418
2022
Q1
$8.39M Sell
35,290
-1,752
-5% -$411K 0.04% 443
2021
Q4
$8.46M Buy
37,042
+2,847
+8% +$626K 0.04% 438
2021
Q3
$6.61M Buy
34,195
+977
+3% +$198K 0.03% 495
2021
Q2
$7.07M Sell
33,218
-2,970
-8% -$627K 0.03% 490
2021
Q1
$7.39M Buy
36,188
+9,213
+34% +$1.81M 0.04% 422
2020
Q4
$4.91M Buy
26,975
+3,541
+15% +$602K 0.03% 538
2020
Q3
$3.92M Buy
23,434
+3,291
+16% +$554K 0.03% 543
2020
Q2
$3.27M Sell
20,143
-5,688
-22% -$1.02M 0.02% 580
2020
Q1
$4.47M Sell
25,831
-6,013
-19% -$1.2M 0.04% 397
2019
Q4
$6.39M Buy
31,844
+1,299
+4% +$266K 0.05% 375
2019
Q3
$6.46M Sell
30,545
-8,567
-22% -$1.79M 0.06% 322
2019
Q2
$7.59M Sell
39,112
-3,927
-9% -$724K 0.07% 274
2019
Q1
$7.08M Buy
43,039
+17,303
+67% +$3.06M 0.07% 272
2018
Q4
$4.84M Buy
25,736
+2,219
+9% +$410K 0.05% 334
2018
Q3
$4M Buy
23,517
+1,482
+7% +$249K 0.04% 438
2018
Q2
$3.61M Buy
22,035
+2,969
+16% +$485K 0.04% 435
2018
Q1
$3.08M Buy
19,066
+7,569
+66% +$1.2M 0.03% 478
2017
Q4
$1.68M Buy
11,497
+4,470
+64% +$637K 0.02% 648
2017
Q3
$953K Sell
7,027
-439
-6% -$55.5K 0.01% 869
2017
Q2
$935K Buy
7,466
+682
+10% +$81.6K 0.01% 835
2017
Q1
$806K Sell
6,784
-993
-13% -$119K 0.01% 826
2016
Q4
$897K Sell
7,777
-371
-5% -$41.3K 0.02% 733
2016
Q3
$852K Buy
8,148
+948
+13% +$99K 0.02% 758
2016
Q2
$701K Buy
7,200
+843
+13% +$79.7K 0.01% 779
2016
Q1
$611K Sell
6,357
-604
-9% -$55K 0.01% 790
2015
Q4
$631K Sell
6,961
-561
-7% -$52.8K 0.01% 751
2015
Q3
$698K Sell
7,522
-199
-3% -$18.9K 0.02% 617
2015
Q2
$719K Sell
7,721
-112
-1% -$10.4K 0.02% 645
2015
Q1
$742K Buy
7,833
+807
+11% +$74.8K 0.02% 620
2014
Q4
$623K Buy
7,026
+589
+9% +$49.9K 0.02% 666
2014
Q3
$515K Buy
6,437
+322
+5% +$24.3K 0.02% 814
2014
Q2
$434K Sell
6,115
-5,977
-49% -$421K 0.02% 821
2014
Q1
$895K Buy
12,092
+938
+8% +$70.8K 0.03% 465
2013
Q4
$875K Buy
11,154
+1,243
+13% +$97.3K 0.04% 441
2013
Q3
$732K Buy
9,911
+590
+6% +$43.5K 0.03% 475
2013
Q2
$708K Buy
+9,321
New +$612K 0.04% 416

Other funds holding CME

Cambridge Investment Research Advisors's CME Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its CME Group (CME) stake by 3.7% in Q2 2026, buying an estimated $487K and bringing the position to 49,827 shares worth $11M. The position accounts for 0.02% of the portfolio, ranked #630.

Cambridge Investment Research Advisors first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.2M in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Cambridge Investment Research Advisors held 49,827 shares of CME Group worth $11M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 1,762 CME Group shares in Q2 2026, an estimated $487K.
  • CME Group made up 0.02% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #630 holding.
  • Cambridge Investment Research Advisors first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
  • Cambridge Investment Research Advisors's CME Group position peaked at $14.2M in Q1 2026.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.